Novo Holdings Lava Therapeutics Nv Transaction History

Novo Holdings

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$1.17 - $1.58 $610,513 - $824,453	-521,806 Reduced 21.74%	1,878,194 $2.97 Million
Q2 2023 Aug 14, 2023	SELL	$1.4 - $2.6 $938,781 - $1.74 Million	-670,558 Reduced 21.84%	2,400,000 $4.87 Million
Q1 2023 May 15, 2023	SELL	$1.59 - $3.97 $408,238 - $1.02 Million	-256,754 Reduced 7.72%	3,070,558 $5.1 Million
Q1 2021 May 17, 2021	BUY	$12.5 - $15.19 $41.6 Million - $50.5 Million	3,327,312 New	3,327,312 $50.5 Million

3.61M

32.9K

500

Ticker LVTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,797,700
Market Cap $25.5M
Description
LAVA Therapeutics N.V., a clinical-stage immuno-oncology company, focuses on developing cancer treatments. The company, through its Gammabody platform, develops a portfolio of novel bispecific antibodies to engage and leverage the potency and precision of gamma delta T cells to elicit an anti-tumor immune response and enhance outcomes for cancer...

Get notified when there are updates to the investment portfolio of Novo Holdings, based on Form 13F filings with the SEC.

Stay updated on Novo Holdings with notifications on news.